NPY5R and hyperinsulinemic hypoglycemia, familial, 4: Paradoxically, Y5 receptor knockout mice are hyperphagic and are not protected against leptin-deficiency-induced obesity [6], and a Y5 receptor antagonist failed to provide clinically meaningful effects in human weight loss trials [7].